| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |